<Record>
<Term>Platelet Aggregation Inhibitors</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<SemanticType>Chemical Viewed Functionally</SemanticType>
<ParentTerm>Hematologic Agents</ParentTerm>
<ParentTerm>Adjuvant</ParentTerm>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Therapeutic Uses/Hematologic Agents/Platelet Aggregation Inhibitors</ClassificationPath>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Adjuvant/Antiplatelet Agent</ClassificationPath>
<BroaderTerm>Therapeutic Uses</BroaderTerm>
<BroaderTerm>Pharmacologic Actions</BroaderTerm>
<BroaderTerm>Antiplatelet Agent</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Hematologic Agents</BroaderTerm>
<BroaderTerm>Platelet Aggregation Inhibitors</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Adjuvant</BroaderTerm>
<BroaderTerm>Chemical Actions and Uses</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<ChildTerm>Israpafant</ChildTerm>
<ChildTerm>Anagrelide Hydrochloride</ChildTerm>
<ChildTerm>Rocepafant</ChildTerm>
<ChildTerm>Furegrelate</ChildTerm>
<ChildTerm>Pentoxifylline</ChildTerm>
<ChildTerm>Andrographolide</ChildTerm>
<ChildTerm>Anagrelide</ChildTerm>
<ChildTerm>Pamicogrel</ChildTerm>
<ChildTerm>Ibudilast</ChildTerm>
<ChildTerm>3,4-Dihydroxyphenylethanol</ChildTerm>
<ChildTerm>Ticlopidine Hydrochloride</ChildTerm>
<ChildTerm>Atrinositol</ChildTerm>
<ChildTerm>Sarpogrelate</ChildTerm>
<ChildTerm>Eptifibatide</ChildTerm>
<ChildTerm>Xemilofiban Hydrochloride</ChildTerm>
<ChildTerm>Cilostazol</ChildTerm>
<ChildTerm>Dacopafant</ChildTerm>
<ChildTerm>Foropafant</ChildTerm>
<ChildTerm>Midazogrel</ChildTerm>
<ChildTerm>Naftopidil</ChildTerm>
<ChildTerm>Ditazole</ChildTerm>
<ChildTerm>Clopidogrel</ChildTerm>
<ChildTerm>Satigrel</ChildTerm>
<ChildTerm>Clopidogrel Bisulfate</ChildTerm>
<ChildTerm>Pentifylline</ChildTerm>
<ChildTerm>Samixogrel</ChildTerm>
<ChildTerm>Ticlopidine</ChildTerm>
<ChildTerm>Tirofiban Hydrochloride</ChildTerm>
<ChildTerm>Plafibride</ChildTerm>
<ChildTerm>Ozagrel</ChildTerm>
<ChildTerm>Picotamide</ChildTerm>
<Synonym>Platelet Inhibitors</Synonym>
<Synonym>Antiplatelet Agent</Synonym>
<Synonym>Blood Platelet Aggregation Inhibitors</Synonym>
<Synonym>Platelet Aggregation Inhibitors</Synonym>
<Synonym>Blood Platelet Antagonists</Synonym>
<Synonym>Antiplatelet Drugs</Synonym>
<Synonym>Platelet Antiaggregants</Synonym>
<Synonym>Blood Platelet Antiaggregants</Synonym>
<Synonym>Platelet Antagonists</Synonym>
<Synonym>Antiplatelet Agents</Synonym>
<Description>Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.</Description>
<Description>An agent that inhibits platelet aggregation and reduces coagulation in the circulatory system.</Description>
<Source>NCI Thesaurus</Source>
<Source>MeSH</Source>
</Record>
